People with dementia who started on higher doses of Z drugs, such as zaleplon, zolpidem and zopiclone, for sleep disturbance were significantly more likely to develop fractures, hip fractures, ischemic stroke and falls, compared with those who didn't use sedatives, researchers reported in the journal BMC Medicine. They also had increased odds of hospital admission, general practitioner visits, and antibiotic, antidepressant and antipsychotic prescriptions. However, the findings showed that lower Z drug doses also correlated with "minimal or inconsistent" excess adverse outcome risk.
Elevated Z drug doses up adverse events in dementia
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.